Microparticles and PD1 interplay added a prognostic impact in treatment outcomes of patients with multiple myeloma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microparticles and PD1 interplay added a prognostic impact in treatment outcomes of patients with multiple myeloma
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-03
DOI
10.1038/s41598-021-96975-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative and functional characteristics of circulating and bone marrow PD-1- and TIM-3-positive T cells in treated multiple myeloma patients
- (2020) Egor V. Batorov et al. Scientific Reports
- The potential diagnostic power of CD138+ Microparticles from the plasma analysis for multiple myeloma clinical monitoring
- (2019) Zhao‐Yun Liu et al. HEMATOLOGICAL ONCOLOGY
- Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1
- (2019) Michael Timaner et al. ONCOGENE
- Current developments in immunotherapy in the treatment of multiple myeloma
- (2018) Martin Köhler et al. CANCER
- Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies
- (2018) Praful Ravi et al. Blood Cancer Journal
- Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
- (2018) Franz L. Ricklefs et al. Science Advances
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients
- (2018) Anne-Marit Sponaas et al. Oncotarget
- Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
- (2018) Ioanna Keklikoglou et al. NATURE CELL BIOLOGY
- Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL).
- (2017) Antoni Ribas et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1
- (2016) M. Ishibashi et al. Cancer Immunology Research
- Isolation of Human CD138+ Microparticles from the Plasma of Patients with Multiple Myeloma
- (2016) Sabna Rajeev Krishnan et al. NEOPLASIA
- American Society of Hematology Annual Meeting 2014: highlights in multiple myeloma
- (2015) Siobhan V Glavey et al. Expert Review of Hematology
- Erratum: The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies
- (2015) T Dosani et al. Blood Cancer Journal
- T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy
- (2015) D. J. Chung et al. Cancer Immunology Research
- Cellular communication via microparticles: role in transfer of multidrug resistance in cancer
- (2014) Ritu Jaiswal et al. Future Oncology
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Immunotherapy for multiple myeloma
- (2014) Jacalyn Rosenblatt et al. Expert Review of Hematology
- Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma
- (2013) D Atanackovic et al. LEUKEMIA
- Plasma cells release membrane microparticles in a mouse model of multiple myeloma
- (2013) Tarek Benameur et al. MICRON
- Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways
- (2013) Jamie F. Lu et al. PHARMACOLOGICAL RESEARCH
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell Disorders
- (2011) Antonio Coppola et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Multiple myeloma
- (2010) M. A. Dimopoulos et al. ANNALS OF ONCOLOGY
- Microparticles
- (2010) Sebastian F. Mause et al. CIRCULATION RESEARCH
- Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone
- (2010) H Avet-Loiseau et al. LEUKEMIA
- Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF
- (2010) Michael Quigley et al. NATURE MEDICINE
- Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease
- (2009) E. J. van Beers et al. HAEMATOLOGICA
- PD-1 signaling in primary T cells
- (2009) James L. Riley IMMUNOLOGICAL REVIEWS
- Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells
- (2009) M Bebawy et al. LEUKEMIA
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
- Diagnostic role of endothelial microparticles in vasculitis
- (2008) U. Erdbruegger et al. RHEUMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More